SCHEMBL6711779

SCHEMBL6711779

COc1ccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)n(C)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.43
MAPT P10636 5/20 0.42
POLB P06746 1/20 0.41
GRIK1 P39086 1/20 0.39
SMN1; SMN2 Q16637 4/20 0.39
ALDH1A1 P00352 3/20 0.39
ROCK1 Q13464 1/20 0.39
S1PR4 O95977 1/20 0.39
TSHR P16473 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HSD17B10 Q99714 2/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
HPGD P15428 2/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
GRM4 Q14833 1/20 0.38
PPARG P37231 1/20 0.38
PPARD Q03181 1/20 0.38
PPARA Q07869 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6709833 0.90 MAPT (0.42) MAPTPOLBGRIK1SMN1; SMN2ALDH1A1
SCHEMBL6755069 0.90 MAPT (0.49) MAPTGRIK1SMN1; SMN2ALDH1A1TSHR
SCHEMBL6707744 0.89 RXFP1 (0.40) RXFP1MAPTGRIK1ROCK1GRM4
SCHEMBL6707925 0.89 RXFP1 (0.39) RXFP1MAPTGRIK1ROCK1GRM4
SCHEMBL6709188 0.87 SRD5A2 (0.42) RXFP1MAPTGRIK1ROCK1MEN1
SCHEMBL6708946 0.87 KDM1A (0.41) RXFP1GRIK1ROCK1GRM4KDM1A
SCHEMBL6713555 0.87 RXFP1 (0.46) RXFP1POLBGRIK1SMN1; SMN2ALDH1A1
SCHEMBL6710298 0.87 GRM4 (0.51) RXFP1GRIK1ROCK1NPC1RAB9A
SCHEMBL6713186 0.86 RXFP1 (0.42) RXFP1GRIK1SMN1; SMN2ALDH1A1ROCK1
SCHEMBL6708850 0.86 KDM1A (0.41) RXFP1GRIK1ROCK1GRM4KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 RXFP1 3836/4885MAPT 4754/4885POLB 626/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.